On Friday, Applied Therapeutics Inc (NASDAQ: APLT) opened higher 13.74% from the last session, before settling in for the closing price of $0.75. Price fluctuations for APLT have ranged from $0.29 to $10.62 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 26.57% over the past five years. Company’s average yearly earnings per share was noted 24.73% at the time writing. With a float of $126.84 million, this company’s outstanding shares have now reached $141.94 million.
Applied Therapeutics Inc (APLT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Applied Therapeutics Inc is 11.93%, while institutional ownership is 63.24%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.48 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.16) by -0.32. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.73% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.40% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Check out the current performance indicators for Applied Therapeutics Inc (APLT). In the past quarter, the stock posted a quick ratio of 1.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1020.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.44, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Applied Therapeutics Inc (NASDAQ: APLT) saw its 5-day average volume 2.17 million, a negative change from its year-to-date volume of 3.39 million. As of the previous 9 days, the stock’s Stochastic %D was 6.27%.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 45.84%, which indicates a significant increase from 13.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1391 in the past 14 days, which was higher than the 0.0794 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8550, while its 200-day Moving Average is $0.5547. Nevertheless, the first resistance level for the watch stands at $0.8829 in the near term. At $0.9158, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9816. If the price goes on to break the first support level at $0.7842, it is likely to go to the next support level at $0.7184. Assuming the price breaks the second support level, the third support level stands at $0.6855.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
There are currently 144,012K shares outstanding in the company with a market cap of 122.41 million. Presently, the company’s annual sales total 460 K according to its annual income of -105,620 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -21,330 K.
